ACC Mystery Product Question

Quote

Anonymous

Guest
I am interviewing for an ACC position, and I have a question about future products. I hear rumors that there is some potential secret-squirrel product launch on the horizon for Hospira. Not Dyloject, its something in addition that would launchin 2013 or 2014, best I can tell... I have come across a few possible candidates in my research, but who knows if I am on the right track or not... Can anyone shed any light on this mystery product? Thanks in advance!
 






Everything is a secret here....even our sales numbers that we haven't seen since July!

I wouldn't put much stock in another product. Even if it comes to pass, I doubt very seriously that it will be anything major....i.e., Voluven, Dyloject, and the deceased Posidur.

We are looking into the pain market, but if whatever it is is a major advance, another company will surely grab it before we do.

Precedex is a great product, but you must know it's gone soon to generic competition.

If you're desperate for a job, OK, if not, keep looking.
 












Anonymous said:
How about those Fu$king numbers already-What if we didn't give our SF calls-Mgt would whine like litttle bitches. Q3 was in total blindness
Click to expand...

This whole company is in total blindness ALL the time! Who are they kidding, IT problems...bullshit. Screwing with the numbers? Worried people will be exiting when they see the bottom falling out? Dennis and Kelly just treading water to save their jobs. You can fool some of the people some of the time, but you can't fool all of the people all of the time....even though Obama tried to and failed.
 






There has been very little information regarding the future product. As of right now, it looks like Precedex will keep us busy through most if not all of next year. That dosen't help you out much as even if you accepted the job today, it would be a while until your through training etc.

I'll say this, most companies are dealing with product situations in one form or another. I'm at Hospira becuase the previous company I work for eliminated the hosptal division when our product went generic. My gut tells me that Hospira has a better chance than most to stay in this market because of the product mix and the ACCS concept of being market focused as opposed to product focused.

Also, they pay well...very well on the product bonus. In the end I guess it all depends on what else you have on the table. I'd like to know the secret product as much as you, but I think you'll have to make a decision without that information
 






Anonymous said:
There has been very little information regarding the future product. As of right now, it looks like Precedex will keep us busy through most if not all of next year. That dosen't help you out much as even if you accepted the job today, it would be a while until your through training etc.

I'll say this, most companies are dealing with product situations in one form or another. I'm at Hospira becuase the previous company I work for eliminated the hosptal division when our product went generic. My gut tells me that Hospira has a better chance than most to stay in this market because of the product mix and the ACCS concept of being market focused as opposed to product focused.

Also, they pay well...very well on the product bonus. In the end I guess it all depends on what else you have on the table. I'd like to know the secret product as much as you, but I think you'll have to make a decision without that information[/Q

Pay well???.....As compared to whom? Salary lower, benes are terrible, car wtf/ lol, bonus is fair and compared to big pharma, this company gets it, sales are a process not a one shot thing. You could do a lot worse...but there are better.
Click to expand...
 






This is all helpful feedback, and I really appreciate those who have taken the time to respond thoughtfully. I agree about the low base, but a decent bonus does balance things a bit (so long as there is reasonable ability to earn it). I am very impressed by what I have seen (from my limited vantage point) with respect to the sales training model.

I am weighing my options between this opportunity and a position with another pharma company as kindof a business development specialist. The pay would be better there, but I am concerned about that company's propensity for reorgs and layoffs. One of their actual performance competencies is how well one can "thrive in ambiguity." Scary in light of their recent past.

Perhaps I shouldn't worry about any of this until an offer is made. Does anyone know how long I might have to make a decision if I were extended an offer?
 






I would think your time frame for a decision would depend upon when the next training session is scheduled. If you've gotten an answer to that, then you'll have a feel for how much time. You should get a few weeks of home study before heading out, but it is not uncommon for reps to be hired Friday and flying to Chicago for two weeks of training on Sunday.
 












Anonymous said:
I am interviewing for an ACC position, and I have a question about future products. I hear rumors that there is some potential secret-squirrel product launch on the horizon for Hospira. Not Dyloject, its something in addition that would launchin 2013 or 2014, best I can tell... I have come across a few possible candidates in my research, but who knows if I am on the right track or not... Can anyone shed any light on this mystery product? Thanks in advance!
Click to expand...

Bogus post by wuss boy and responses from himself to himself
guy is SICK SICK SICK look them up you will see thousands on here (no joke)

HR GUY

HR GUY
 






Anonymous said:
Bogus post by wuss boy and responses from himself to himself
guy is SICK SICK SICK look them up you will see thousands on here (no joke)

HR GUY

HR GUY
Click to expand...

Get a life you loser. Not surprised you were/are a typical shit-for-brains HR lackey.
Bogus post or not, the responses are valid. Hospira utilizes the "mushroom theory", i.e keep everyone in the dark and feed them a lot of horse manure.

I doubt any vacant positions will be filled...just absorbed. Once generic, a product will hold maybe 50% of its market share for 6 mos. After that it's anyone's guess....all based on the price of the product, its position on the contracts,hospital/insurance formularies, etc.
The pre-fill will retain many customers, providing there isn't a premium price for it. ACC will undoubtedly keep all or most of the reps thru Dec. Then, based on how much generic erosion takes place for Precedex, you will definitely see an adjustment in numbers.

You HR morons simply take orders from upper mgmnt. You do what you are told to keep the company out of lawsuits. You distort truth, aka. LIE, to screw individuals. You know nothing but what you are told. Please, disappear from CP; you and your posts are very annoying.

Sales Management Guy
 






Anonymous said:
Get a life you loser. Not surprised you were/are a typical shit-for-brains HR lackey.
Bogus post or not, the responses are valid. Hospira utilizes the "mushroom theory", i.e keep everyone in the dark and feed them a lot of horse manure.

I doubt any vacant positions will be filled...just absorbed. Once generic, a product will hold maybe 50% of its market share for 6 mos. After that it's anyone's guess....all based on the price of the product, its position on the contracts,hospital/insurance formularies, etc.
The pre-fill will retain many customers, providing there isn't a premium price for it. ACC will undoubtedly keep all or most of the reps thru Dec. Then, based on how much generic erosion takes place for Precedex, you will definitely see an adjustment in numbers.

You HR morons simply take orders from upper mgmnt. You do what you are told to keep the company out of lawsuits. You distort truth, aka. LIE, to screw individuals. You know nothing but what you are told. Please, disappear from CP; you and your posts are very annoying.

Sales Management Guy
Click to expand...

Wuss boy posing again ! He couldn't manage a candy store And Definitely CANT manage his pathetic life !!! Fired from ACCS Never a Manager

HR GUY
 






Anonymous said:
Get a life you loser. Not surprised you were/are a typical shit-for-brains HR lackey.
Bogus post or not, the responses are valid. Hospira utilizes the "mushroom theory", i.e keep everyone in the dark and feed them a lot of horse manure.

I doubt any vacant positions will be filled...just absorbed. Once generic, a product will hold maybe 50% of its market share for 6 mos. After that it's anyone's guess....all based on the price of the product, its position on the contracts,hospital/insurance formularies, etc.
The pre-fill will retain many customers, providing there isn't a premium price for it. ACC will undoubtedly keep all or most of the reps thru Dec. Then, based on how much generic erosion takes place for Precedex, you will definitely see an adjustment in numbers.

You HR morons simply take orders from upper mgmnt. You do what you are told to keep the company out of lawsuits. You distort truth, aka. LIE, to screw individuals. You know nothing but what you are told. Please, disappear from CP; you and your posts are very annoying.

Sales Management Guy
Click to expand...

News Flash! Flash!
New product is on its way to us; it is dylodex!
Dyloject plus Precedex ...pain relief plus sedation. A potential blockbuster if it's marketed properly. We are working with Endo on this and it looks like a Q3 2015 launch date. Thank you Dennis and Kelly
 


















Kookie Goebbels Mires has a gold plated resume but is insufferably pompass and arrogant towards employees which only helps acidify the 'Swamp'. SLT are you listening? Hello? I can only assume you don't address this because you plan is to sell this rotten ship.
 
























Dyloject training modules to be sent 12/24 and completed by 1/9/15.
Expected FDA approval early fourth quarter and launch by February.
I have been doing a pre-launch of my own with some AN's and am getting some very positive feedback. Price always comes up.....priced right it will sell wrong it will not be added to any formularies as most are on 0 increase with drug costs.

Hope you're listening marketing and Dennis. Screw this up and we are definitely in deep shit with no boots.
 






Top Bottom
Back
Quote